AdaptHealth reports FY2024 net income of $90.4M vs prior year loss; revenue up 1.9%

AdaptHealth Corp.

2024-FY EPS reported $0.61 revenue$3,260,975,000

FY2024 net revenue $3.261B (+1.9% YoY); net income attributable $90.4M vs net loss $678.9M.
Adjusted EBITDA $688.7M (+2.7% YoY); cash flow from ops $541.8M, free cash flow $235.8M.
Q4 net revenue $856.6M (-0.2% YoY); net income $50.3M vs loss $254.5M; adjusted EBITDA $200.6M.
FY2025 guidance: net revenue $3.22B-$3.36B; adjusted EBITDA $670M-$710M; free cash flow $180M-$220M.
Reached definitive agreement to sell certain incontinence assets in Wellness at Home segment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.